AI-driven risk prediction system utilizing continuous vital sign monitoring for patient deterioration forecasting. Enables early intervention and risk stratification in clinical populations.
Manufactured by
China
Wuhan Jiule Technology Co., Ltd., established in 2012, provides health management services focusing on automated life monitoring, early warning, and risk intervention for individuals with limited mobility. The company has developed wearable health monitoring devices with NMPA Class II medical device certification. Solutions are applied in smart hospital wards, remote rehabilitation, intelligent follow-up, emergency care, and occupational health monitoring for industries including power, construction, and transportation.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
a.cure
South Korea · 1 relevant product
Advanced Tactile Imaging, Inc.
United States · 1 relevant product
APOLO AI SYSTEMS AND DEVELOPMENT S.L.
Spain · 1 relevant product
Optain Health
Australia · 1 relevant product
Siemens Healthineers
United States · 1 relevant product
TALOS Corp.
South Korea · 1 relevant product
Cardiex Limited
China · 1 relevant product
EXOSYSTEMS Inc.
South Korea · 1 relevant product
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
8 of 8 closest product alternatives
a.cure · South Korea
An AI-powered diagnostic system that analyzes voice characteristics to predict heart failure severity and pulmonary congestion levels. The technology identifies risk signals through voice biomarkers, enabling early detection of cardiovascular complications.
Advanced Tactile Imaging, Inc. · United States
A diagnostic system that predicts preterm delivery risk through biomechanical evaluation of cervical and pelvic floor properties. It provides objective data to guide pregnancy management and preventive interventions.
APOLO AI SYSTEMS AND DEVELOPMENT S.L. · Spain
Artificial intelligence system designed to identify subtle disease indicators through analysis of medical data. The technology enables early detection and timely clinical intervention for more effective patient treatment outcomes.
Optain Health · Australia
Non-invasive screening system utilizing AI algorithms to detect referable retinal diseases and chronic conditions from fundus images. The system generates comprehensive health risk reports for population screening and disease risk stratification.
Siemens Healthineers · United States
Integrated testing platform providing comprehensive evaluation of cardiometabolic health parameters for earlier risk detection. Supports longitudinal monitoring and holistic patient assessment.
TALOS Corp. · South Korea
An artificial intelligence algorithm that evaluates clinical data to predict brain aneurysm risk levels in patients. The system provides quantitative risk stratification to support clinical decision-making for preventive interventions. Applicable to screening programs across healthcare organizations.
Cardiex Limited · China
Digital vascular biomarker platform for arterial health screening and remote cardiovascular monitoring. Enables point-of-care risk stratification, early disease detection, and progression tracking through non-invasive assessment of arterial stiffness and vascular health status.
EXOSYSTEMS Inc. · South Korea
A digital biomarker-based monitoring system designed for tracking disease progression and treatment response in musculoskeletal conditions. The platform enables objective, quantifiable follow-up assessments with reduced subjectivity and improved accessibility for patients with mobility limitations.
© 2026 Suplivia · Home · Browse Products